TF and breast carcinoma: Since dysregulated TF–DNA interactions are key drivers in breast cancer progression, understanding the relationship between G4s, i-motifs, and TFs will help to uncover new therapeutic strategies for inhibiting EMP and modulating the epigenetic regulation of gene expression.